Login/Sign Up
Biomab Egfr 50 mg Injection 1's belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. It may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Biomab Egfr 50 mg Injection 1's contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
In some cases, Biomab Egfr 50 mg Injection 1's may cause side effects like fever, chills, headache, itching, and mucositis. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
Do not use Biomab Egfr 50 mg Injection 1's if you are allergic to any of its components. Consult the doctor if you are pregnant or breastfeeding. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
Biomab Egfr 50 mg Injection 1's belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. Biomab Egfr 50 mg Injection 1's contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer. Nimotuzumab may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Do not use Biomab Egfr 50 mg Injection 1's if you are allergic to any of its components. Inform the doctor if you are pregnant or breastfeeding. Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection 1's in children. Let the doctor know if you have any health conditions or if you are taking any medications, including herbal supplements.
Drug-Drug Interactions: No interactions found/established.
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: No interactions found/established.
Head and neck cancer: Head and neck cancer includes cancer in the throat, larynx, nose, lips, mouth, and salivary glands. The risk of head and neck cancer increases with heavy alcohol use, tobacco use, and infection with human papillomavirus (HPV). Symptoms include persistent sore throat, changes in voice, trouble swallowing, and a sore or lump that does not heal.
About Biomab Egfr 50 mg Injection 1's
Biomab Egfr 50 mg Injection 1's belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. It may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Biomab Egfr 50 mg Injection 1's contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
In some cases, Biomab Egfr 50 mg Injection 1's may cause side effects like fever, chills, headache, itching, and mucositis. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
Do not use Biomab Egfr 50 mg Injection 1's if you are allergic to any of its components. Consult the doctor if you are pregnant or breastfeeding. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
₹48979*
MRP ₹59730.5
18% off
₹49883.97*
MRP ₹59730.5
15% CB
₹9846.53 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Uses of Biomab Egfr 50 mg Injection 1's
Medicinal Benefits
Biomab Egfr 50 mg Injection 1's belongs to the group of anti-cancer medicines used to treat head and neck cancer with concurrent chemotherapy and/or radiotherapy. Biomab Egfr 50 mg Injection 1's contains Nimotuzumab, a recombinant humanised monoclonal antibody that works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer. Nimotuzumab may also be indicated in the treatment of glioma (growth of tumours in the brain or spinal cord) and nasopharyngeal cancer.
Side Effects of Biomab Egfr 50 mg Injection 1's
Directions for Use
Storage
Drug Warnings
Do not use Biomab Egfr 50 mg Injection 1's if you are allergic to any of its components. Inform the doctor if you are pregnant or breastfeeding. Please consult the doctor if you have any concerns regarding the usage of Biomab Egfr 50 mg Injection 1's in children. Let the doctor know if you have any health conditions or if you are taking any medications, including herbal supplements.
Therapeutic Class
Diet & Lifestyle Advise
Habit Forming
Disease/Condition Glossary
Head and neck cancer: Head and neck cancer includes cancer in the throat, larynx, nose, lips, mouth, and salivary glands. The risk of head and neck cancer increases with heavy alcohol use, tobacco use, and infection with human papillomavirus (HPV). Symptoms include persistent sore throat, changes in voice, trouble swallowing, and a sore or lump that does not heal.